Oragenics Inc (OGEN)

Finanzdaten der Oragenics Inc-Aktie (OGEN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-03-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	14.92%2.59	2.26	2.50	3.12	1.71
Research and Development	82.29%1.18	0.65	0.67	0.93	0.45
Operating Income/Loss	14.92%-2.59	-2.26	-2.50	-3.12	-1.71
Nonoperating Income/Loss	45.59%0.02	0.03	0.07	0.06	-0.56
Income/Loss From Continuing Operations Before Tax	15.79%-2.58	-2.22	-2.22	-3.07	-2.27
Income Tax Expense/Benefit	104.98%-0.05	-0.02	-	-	-
	14.88%-2.53	-2.20	-2.29	-3.07	-2.27
Attributable To Parent	14.88%-2.53	-2.20	-2.29	-3.07	-2.27
Basic Average Shares	2.97%4.43	4.30	18.22	1.56	0.73
Diluted Average Shares	2.97%4.43	4.30	18.22	1.56	0.73
Basic Earnings Per Share	11.76%-0.57	-0.51	-0.12	-1.96	-3.10
Diluted Earnings Per Share	11.76%-0.57	-0.51	-0.12	-1.96	-3.10